Dr. Nathan Katz, co-founder, CEO, and Chief Scientist at Jointechlabs, following his PhD in cell biology quickly became part of the growing field of stem cells and reproductive medicine.
Shortly afterward, foundational papers were presented on adipose-derived stem cells which intrigued Dr. Katz, and since then he had a specific motivation for exploring these disciplines since his mother was suffering the debilitating effects of osteoarthritis.
After years of research and testing, Dr. Katz co-founded Jointechlabs to promote efficient ways of adipose regenerative cells harvest, which can then be used for several therapeutic applications.
The company was founded on the principle of making available efficient, affordable adipose regenerative cell therapies to all doctors and patients around the world. This principle continues to guide the company today, as does COO and Chief Medical Officer Dr. Nishit Pancholi, co-founder of Jointechlabs, moving forward the field of regenerative medicine with the goal of making it an available standard of care option for doctors and patients. Their combined efforts have led to novel product developments enabling healthcare professionals to offer affordable autologous adipose-based therapies for their patients at the point-of-care.